{"protocolSection":{"identificationModule":{"nctId":"NCT03838341","orgStudyIdInfo":{"id":"ThR-LAAO-PL"},"organization":{"fullName":"Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland","class":"OTHER"},"briefTitle":"Stand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation.","officialTitle":"Stand-Alone Thoracoscopic Epicardial Left Atrial Appendage Occlusion With AtriClip® Device for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation - the Polish Nationwide Registry.","acronym":"THORACS-LAAO"},"statusModule":{"statusVerifiedDate":"2019-03","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-06-08","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2020-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-01-01","type":"ESTIMATED"},"studyFirstSubmitDate":"2019-01-27","studyFirstSubmitQcDate":"2019-02-09","studyFirstPostDateStruct":{"date":"2019-02-12","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-03-02","lastUpdatePostDateStruct":{"date":"2019-03-05","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Piotr Suwalski, PhD","investigatorTitle":"Doctor of Philosophy","investigatorAffiliation":"Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland"},"leadSponsor":{"name":"Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUsExport":true},"descriptionModule":{"briefSummary":"Polish multicenter registry to assess safety and durability of totally thoracoscopic left atrial appendage occlusion for stroke prevention in atrial fibrillation.","detailedDescription":"The THORACS-LAAO Registry is the Polish multi-institutional registry of the consecutive patients with atrial fibrillation assigned for the totally thoracoscopic left atrial appendage occlusion (LAAO) for stroke prevention with designed epicardial clip AtriClip®. The registry has no limit of the number of patient included. Patients will be followed up with transoesophageal echocardiography at 6-12 months to assess the durability of left atrial appendage (LAA) oclusion and collect the informations about possible adverse events."},"conditionsModule":{"conditions":["Stroke Prevention","Atrial Fibrillation","Safety Issues"],"keywords":["Stroke prevention","Atrial fibrillation","Totally thoracoscopic","LAAO","AtriClip®"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"5 Years","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":100,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Included","description":"The consecutive patients with atrial fibrillation assigned to totally thoracoscopic stand-alone left atrial appendage occlusion using AtriClip® for stroke prevention.","interventionNames":["Device: AtriClip™ LAA Exclusion System","Drug: Oral anticoagulation therapy"]}],"interventions":[{"type":"DEVICE","name":"AtriClip™ LAA Exclusion System","description":"The left atrial appendage is closed from the epicardial side of the heart. Operative access is totally thoracoscopic. The designed and dedicated clip - AtriClip® (AtriCure, Ohio, USA) is introduced to the left pleura through thoracoscopic port.","armGroupLabels":["Included"],"otherNames":["AtriClip LAA Exclusion System and Delivery System (LAAØ)","AtriClip LAA Exclusion System and Delivery System (PRO1)","AtriClip LAA Exclusion System and Delivery System (PRO2)"]},{"type":"DRUG","name":"Oral anticoagulation therapy","description":"Anticoagulation therapy discontinuation - according to the standard of care at the discretion of the Investigator.","armGroupLabels":["Included"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Perioperative complications","description":"Number of perioperative complications associated with AtriClip placement","timeFrame":"First 5 postoperative days"},{"measure":"Intraoperative success of exclusion of LAA.","description":"Successful exclusion of LAA is defined as no communication between LAA and LA and \\< 5 mm LAA remnant measured by intraoperative transesophageal echo with Doppler.","timeFrame":"Intraoperatively"}],"secondaryOutcomes":[{"measure":"Major adverse cardiac and cerebrovascular events (MACCE)","description":"Number of Participants with combined end point of death, acute heart failure, myocardial infarction and stroke.","timeFrame":"5 years"},{"measure":"Pulmonary complications.","description":"Number of participants requiring prolonged mechanical ventilation postoperatively","timeFrame":"Up to 30 days post operation"},{"measure":"Any complications connected with surgical intervention","description":"Rate of bleeding requiring transfusion or re-operation, phrenic nerve palsy, oedema requiring intervention, wound infection, abscess in pleura","timeFrame":"Up to 30 days post operation"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\>18 years\n* Lone atrial fibrillation\n* Previous stroke or systemic thromboembolic complications\n* High risk of thromboembolic complications assessed with CHA2DS2-VASc Score \\>2\n* High bleeding risk assessed with HASBLED score =\\> 2.\n* Contraindications to oral anticoagulation\n* Complications of the oral anticoagulation\n* Acceptable surgical candidate, including use of general anaesthesia\n\nExclusion Criteria:\n\n* Patient refusal\n* Significant valve disease or coronary multi-vessel artery lesions requiring surgery\n* Stroke/cerebrovascular accident (CVA) within previous 30 days\n* Critical preoperative state\n\nIntra-Operative Exclusion Criteria\n\n* Presence of thrombus in the left atrium or LAA as documented on intra-operative transesophageal echocardiography\n* LAA tissue with significant adhesions (as evaluated by the surgeon) carries AtriClip placement overly risky.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"The registry will include all patients with atrial fibrillation with high risk of thromboembolic complications - CHA2DS2-VASc Score \\>2 and HASBLED score of =\\> 2 refered to primary or secondary stroke prevention who do not require open chest surgery for other reasons.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Piotr Suwalski, PhD","role":"CONTACT","phone":"+48225081269","email":"suwalski.piotr@gmail.com"},{"name":"Anna Witkowska, MD","role":"CONTACT","phone":"+48662076716","email":"vera@rallywitkowscy.pl"}],"overallOfficials":[{"name":"Piotr Suwalski, PhD","affiliation":"Central Clinical Hospital of Ministry of the Interior and Administration in Warsaw","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Central Clinical Hospital of Ministry of the Interior and Administration in Warsaw","status":"RECRUITING","city":"Warsaw","zip":"02-507","country":"Poland","contacts":[{"name":"Piotr Suwalski, PhD","role":"CONTACT","phone":"+48225081269","email":"suwalski.piotr@gmail.com"},{"name":"Anna Witkowska, MD","role":"CONTACT","phone":"+48662076716","email":"vera@rallywitkowscy.pl"}],"geoPoint":{"lat":52.22977,"lon":21.01178}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M16372","name":"Thromboembolism","relevance":"LOW"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}